Author Question: Kathryn has completed a study and rejected the null hypothesis when it was false. Kathryn has made a ... (Read 225 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
Kathryn has completed a study and rejected the null hypothesis when it was false. Kathryn has made a _________.
 
  a. correct decision.
  b. a type I error.
  c. a type II error.
  d. a type III error.

Question 2

Look at the research matrix below without column headings. If you wanted to have 10 participants for each condition, how many participants would you need for a within subjects factorial design?
  Angry Angry
  Non-confrontational Confrontational
 
  Exciting Exciting
  Non-confrontational Confrontational
  Neutral Neutral
  Non-confrontational Confrontational
 
  a. 10
  b. 20
  c. 40
  d. 60



macybarnes

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

A

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

It is believed that the Incas used anesthesia. Evidence supports the theory that shamans chewed cocoa leaves and drilled holes into the heads of patients (letting evil spirits escape), spitting into the wounds they made. The mixture of cocaine, saliva, and resin numbed the site enough to allow hours of drilling.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library